These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 21441467

  • 41. Effects of dosing protocol on distribution of propranolol in periocular tissues after topical ocular instillation.
    Liu H, Yang MB, Li SK, Hao J.
    Curr Eye Res; 2015 May; 40(6):638-45. PubMed ID: 25167079
    [Abstract] [Full Text] [Related]

  • 42. Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.
    Zhang L, Zhang J, Wang L, Xia H.
    Curr Eye Res; 2009 Apr; 34(4):257-63. PubMed ID: 19373573
    [Abstract] [Full Text] [Related]

  • 43. Ocular distribution of cyclosporin A (Sandimmun) following systemic and topical administration to rabbits.
    Vernillet L, Lundh RL, Acezat-Mispelter F, Goizel C, Humbert H, Pouliquen Y.
    Eur J Drug Metab Pharmacokinet; 1991 Apr; Spec No 3():150-8. PubMed ID: 1820870
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Ocular pharmacokinetics of naringenin eye drops following topical administration to rabbits.
    Lin J, Sun J, Wang Y, Ma Y, Chen W, Zhang Z, Gui G, Lin B.
    J Ocul Pharmacol Ther; 2015 Feb; 31(1):51-6. PubMed ID: 25229266
    [Abstract] [Full Text] [Related]

  • 47. Ocular pharmacokinetics of fluocinolone acetonide following Iluvien implantation in the vitreous humor of rabbits.
    Kane FE, Green KE.
    J Ocul Pharmacol Ther; 2015 Feb; 31(1):11-6. PubMed ID: 25562126
    [Abstract] [Full Text] [Related]

  • 48. Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation.
    Akpek EK, Vittitow J, Verhoeven RS, Brubaker K, Amar T, Powell KD, Boyer JL, Crean C.
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):433-9. PubMed ID: 19857105
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Ocular disposition of aminozolamide in the rabbit eye.
    Putnam ML, Schoenwald RD, Duffel MW, Barfknecht CF, Segarra TM, Campbell DA.
    Invest Ophthalmol Vis Sci; 1987 Aug; 28(8):1373-82. PubMed ID: 3610554
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.
    Chang-Lin JE, Attar M, Acheampong AA, Robinson MR, Whitcup SM, Kuppermann BD, Welty D.
    Invest Ophthalmol Vis Sci; 2011 Jan 05; 52(1):80-6. PubMed ID: 20702826
    [Abstract] [Full Text] [Related]

  • 56. Comparison of the ocular distribution of a model oligonucleotide after topical instillation in rabbits of conventional and new dosage forms.
    Bochot A, Mashhour B, Puisieux F, Couvreur P, Fattal E.
    J Drug Target; 1998 Jan 05; 6(4):309-13. PubMed ID: 9894698
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.